BR112015009105A2 - esfera, polímero de hialuronato e glucomanana, usos de um polímero de hialuronato e glucomanana e de uma esfera, composição cosmética ou dermatológica para administração tópica, e, processo para sintetizar uma esfera - Google Patents

esfera, polímero de hialuronato e glucomanana, usos de um polímero de hialuronato e glucomanana e de uma esfera, composição cosmética ou dermatológica para administração tópica, e, processo para sintetizar uma esfera

Info

Publication number
BR112015009105A2
BR112015009105A2 BR112015009105A BR112015009105A BR112015009105A2 BR 112015009105 A2 BR112015009105 A2 BR 112015009105A2 BR 112015009105 A BR112015009105 A BR 112015009105A BR 112015009105 A BR112015009105 A BR 112015009105A BR 112015009105 A2 BR112015009105 A2 BR 112015009105A2
Authority
BR
Brazil
Prior art keywords
sphere
hyaluronate
glucomannan
polymer
glucomannan polymer
Prior art date
Application number
BR112015009105A
Other languages
English (en)
Other versions
BR112015009105B1 (pt
Inventor
Napp Erc
Dureux Florent
Bonnet Isabelle
Original Assignee
Basf Beauty Care Solutions France Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Beauty Care Solutions France Sas filed Critical Basf Beauty Care Solutions France Sas
Publication of BR112015009105A2 publication Critical patent/BR112015009105A2/pt
Publication of BR112015009105B1 publication Critical patent/BR112015009105B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/025—Explicitly spheroidal or spherical shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087—Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof
    • C08B37/009—Konjac gum or konjac mannan, i.e. beta-D-glucose and beta-D-mannose units linked by 1,4 bonds, e.g. from Amorphophallus species; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/546—Swellable particulate polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Abstract

1 / 1 resumo “esfera, polãmero de hialuronato e glucomanana, usos de um polãmero de hialuronato e glucomanana e de uma esfera, composiã‡ãƒo cosmã‰tica ou dermatolã“gica para administraã‡ãƒo tã“pica, e, processo para sintetizar uma esfera” a presente invenã§ã£o refere-se a uma esfera distinguida por incluir pelo menos um polã­mero de hialuronato e glucomanana. tambã©m se refere a um polã­mero de hialuronato e glucomanana em que cada ligaã§ã£o entre um grupo hialuronato e um grupo glucomanana ã© uma ligaã§ã£o ã©ster. alã©m do mais, refere- se ao processo de produã§ã£o e uso do mesmo, em particular como um agente de preenchimento ou de hidrataã§ã£o.
BR112015009105-9A 2012-10-25 2013-10-24 Esfera, composição cosmética ou dermatológica para administração tópica, processo para sintetizar uma esfera, e, uso de uma esfera BR112015009105B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR1260164 2012-10-25
FR1260164A FR2997406B1 (fr) 2012-10-25 2012-10-25 Polymere de hyaluronate et de glucomannane
US201261718765P 2012-10-26 2012-10-26
US61/718,765 2012-10-26
PCT/FR2013/052546 WO2014064391A1 (fr) 2012-10-25 2013-10-24 Polymere de hyaluronate et de glucomannane.

Publications (2)

Publication Number Publication Date
BR112015009105A2 true BR112015009105A2 (pt) 2017-07-04
BR112015009105B1 BR112015009105B1 (pt) 2021-03-30

Family

ID=47833120

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015009105-9A BR112015009105B1 (pt) 2012-10-25 2013-10-24 Esfera, composição cosmética ou dermatológica para administração tópica, processo para sintetizar uma esfera, e, uso de uma esfera

Country Status (8)

Country Link
US (1) US11439579B2 (pt)
EP (1) EP2912073A1 (pt)
JP (1) JP6301941B2 (pt)
KR (1) KR102168100B1 (pt)
CN (1) CN104870479B (pt)
BR (1) BR112015009105B1 (pt)
FR (1) FR2997406B1 (pt)
WO (1) WO2014064391A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016179269A1 (en) * 2015-05-04 2016-11-10 Makefield Llc Ascorbic acid and biopolymer cosmetic compositions
CN104799642B (zh) * 2015-05-09 2016-02-24 福建农林大学 一种药愈颈椎枕及其制备方法
CN105054292B (zh) * 2015-07-03 2018-09-18 福建农林大学 一种魔芋清口气烟嘴滤芯及其制备方法
CN105496906B (zh) * 2016-01-29 2018-05-11 福建农林大学 芦荟魔芋葡甘聚糖面膜及其制备方法
KR102394532B1 (ko) * 2016-06-30 2022-05-06 (주)아모레퍼시픽 분자량이 상이한 히알루론산들을 함유하는 화장료 조성물
WO2018090073A1 (en) * 2016-11-16 2018-05-24 Ultraceuticals R&D Pty Ltd Nanospheres for cosmetic and pharmaceutical use
US10660419B2 (en) * 2016-12-15 2020-05-26 Elc Management Llc Packaged skin treatment composition and method
CN108653818B (zh) * 2018-05-24 2020-12-29 上海其胜生物制剂有限公司 一种可逆的胶原刺激填充剂及其制备方法
CN109745582B (zh) * 2019-03-11 2021-11-19 西南科技大学 一种白芨多糖复合细胞支架的制备方法
FR3098719A1 (fr) 2019-07-19 2021-01-22 Laboratoire Promicea Nouvelle composition de maquillage et/ou de soin des lèvres
WO2022104728A1 (en) * 2020-11-20 2022-05-27 L'oreal Composition for caring for a keratin material
CN112870092A (zh) * 2021-01-29 2021-06-01 广州集妍化妆品科技有限公司 一种两相型精华及其制备方法
CA3227409A1 (en) * 2021-08-12 2023-02-16 Roc Opco Llc Composition of hyaluronic acid and use alone and in combination with retinoids to improve skin
CN113925827A (zh) * 2021-10-13 2022-01-14 振德医疗用品股份有限公司 一种失禁护理软膏及其制备方法
CN114682180A (zh) * 2022-03-09 2022-07-01 睿藻生物科技（苏州）有限公司 一种天然虾青素水溶微胶囊及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR595821A (fr) 1924-12-08 1925-10-09 Merck E Procédé pour séparer les liquides en mélange
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
FR2694895B1 (fr) * 1992-08-20 1994-11-10 Coletica Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification.
FR2777193B1 (fr) * 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
WO2002041877A1 (en) * 2000-10-24 2002-05-30 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres
FR2847267B1 (fr) 2002-11-19 2006-07-28 Coletica Procede de test de l'activite d'une substance potentiellement active pour inhiber l'activite enzymatique de la phospholipase a2
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US20050036974A1 (en) 2003-07-17 2005-02-17 L'oreal Beta-endorphin activity in cosmetics and dermatology
FR2882366B1 (fr) * 2005-02-18 2008-04-18 Coletica Sa Polymere reticule de carbohydrate, notamment a base de polysaccharides et/ou de polyols
GB2423252B (en) * 2005-02-18 2007-10-17 Engelhard Lyon Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols
FR2893252B1 (fr) 2005-11-17 2008-02-15 Engelhard Lyon Sa Extraits vegetaux stimulant has2
US20080038780A1 (en) * 2006-02-15 2008-02-14 Novozymes Biopolymer A/S Production of low molecular weight hyaluronic acid
FR2918569B1 (fr) 2007-07-09 2012-09-28 Engelhard Lyon Substances inhibant la glycation des proteines.
AU2008307152B2 (en) * 2007-10-04 2013-10-10 Ultraceuticals R & D Pty Ltd Composition and method for dermal regeneration
FR2929511B1 (fr) 2008-04-02 2010-12-31 Basf Beauty Care Solutions France Sas Nouveau principe actif stimulant la proliferation et/ou l'activite des fibroblastes.
CN102380129B (zh) 2011-10-31 2015-01-28 昆明理工大学 一种透明质酸钠和魔芋葡甘聚糖多孔支架材料及其制备方法

Also Published As

Publication number Publication date
BR112015009105B1 (pt) 2021-03-30
KR20150070394A (ko) 2015-06-24
EP2912073A1 (fr) 2015-09-02
US11439579B2 (en) 2022-09-13
CN104870479A (zh) 2015-08-26
WO2014064391A1 (fr) 2014-05-01
JP2015535307A (ja) 2015-12-10
CN104870479B (zh) 2018-07-06
FR2997406B1 (fr) 2015-07-03
KR102168100B1 (ko) 2020-10-20
JP6301941B2 (ja) 2018-03-28
US20150283055A1 (en) 2015-10-08
FR2997406A1 (fr) 2014-05-02

Similar Documents

Publication Publication Date Title
BR112015009105A2 (pt) esfera, polímero de hialuronato e glucomanana, usos de um polímero de hialuronato e glucomanana e de uma esfera, composição cosmética ou dermatológica para administração tópica, e, processo para sintetizar uma esfera
BR102012006009A2 (pt) composiÇço de partÍcula de microcÁpsula; partÍcula de microcapsula, produto para o cuidado pessoal, terapÊutico, cosmÉtico ou cosmecÊutico, processo para o preparo das partÍculas da microcÁpsula contendo um nécleo de àleo ou lÍquido aquoso, e preparaÇço de partÍculas de microcÁpsula
BR112014029286A2 (pt) composição cosmética sólida, processo para sua produção, produto e método cosmético
BR112014029762A2 (pt) composição contendo n-metil-n-acilglucamina
BR112016012129A8 (pt) métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células
BRPI1105992B8 (pt) Composição para limpeza da pele
BR112014026109A2 (pt) composição para tratamento dos cabelos que compreende ésteres insaturados de poliol metatetizados
BR112014023379A8 (pt) Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
AU2014359194A1 (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology
BR112015018838A2 (pt) estabilidade melhorada de novas composições líquidas
MX354166B (es) Composicion transparente o traslucida.
WO2014044808A3 (en) Fast-penetration cosmetic dermal filler for topical application
BR112014029769A2 (pt) composição contendo n-metil-n-acilglucamina
BR112017010720A2 (pt) gel aquoso ou alcoólico aquoso de filossilicatos sintéticos como agente de viscosidade, de efeito matificante e/ou agente homogeneizador de aplicação
BR112018068559A2 (pt) ácido hialurônico modificado, método de fabricação do mesmo e usos do mesmo
BR112015031329A2 (pt) composições compreendendo ciclodextrina e ácido hialurônico reticulado
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
BR112015010392A2 (pt) composição para tratamento de pele
AU2013269583A8 (en) Oil/water-emulsion-type topical compositions containing a retinoid
BR112016007671A2 (pt) adição em estágio tardio de modificador de reologia
BR112015007045A2 (pt) composição de cuidado pessoal
BR112017009811A2 (pt) composição e método para a modelagem de cabelo
BR112014032254A2 (pt) processo para a preparação de uma composição, aparelho, e, uso de um aparelho
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
BR112015029069A2 (pt) método para preparar uma espuma a partir de um polímero de condensação polimerizável

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2013, OBSERVADAS AS CONDICOES LEGAIS.